BioCentury
ARTICLE | Management Tracks

City Therapeutics adds to C-suite

Plus: Updates from EnPlusOne, Design, Werewolf, Ardelyx and Aim Vaccine

April 17, 2025 10:52 PM UTC

City Therapeutics Inc., the siRNA company launched last year by founding Alnylam Inc. CEO John Maraganore, named Baisong Mai CMO following a stint as EVP and CMO of Editas Medicine Inc. (NASDAQ:EDIT). City also named former Alnylam employee Anna O’Driscoll chief human resources officer; she had been at Cellarity Inc. since 2022.

RNA synthesis and manufacturing company Enplusone Biosciences Inc. hired Clare Murray as CEO. Murray was SVP of corporate development and operations at Life Edit Therapeutics Inc., which Elevatebio LLC acquired...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article